Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
2.770
+0.030 (1.09%)
Oct 26, 2026, 3:32 PM EDT - Market open
UPB's stock price has decreased by -87.24% in the past year and price targets may not have had time to catch up.
Upstream Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +1,199.64% | Sep 2, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $19 | Buy | Maintains | $19 | +585.92% | Sep 2, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +224.91% | Aug 14, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $43 → $25 | Buy | Maintains | $43 → $25 | +802.53% | Aug 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $75 | Buy | Maintains | $75 | +2,607.58% | Jun 25, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |